Different studies suggested that TM could dictate BTZ efficacy, as shown by TM-induced MM morphological alterations, differentiation, and maturation, accompanied by elevated secretion of Ig light chains and UPR-dependent transcription. The gene discussed is CASC3; the disease is Miyoshi myopathy.